Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nikola Pandrc
Cost/Effectiveness of Aripiprazole vs. Olanzapine in the Long-Term Treatment of Schizophrenia
Srpski Arhiv Za Celokupno Lekarstvo
Medicine
Related publications
Cost-Effectiveness Analysis of Lurasidone and Olanzapine in the Treatment of Schizophrenia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy and Safety of Aripiprazole vs. Haloperidol for Long-Term Maintenance Treatment Following Acute Relapse of Schizophrenia
International Journal of Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
The GiSAS Study: Rationale and Design of a Pragmatic Randomized Controlled Trial on Aripiprazole, Olanzapine and Haloperidol in the Long-Term Treatment of Schizophrenia
Contemporary Clinical Trials
Medicine
Pharmacology
Cost Effectiveness of Paliperidone Palmitate Versus Risperidone Long-Acting Injectable, Quetiapine and Olanzapine for the Treatment of Patients With Schizophrenia in Colombia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Risperidone vs Olanzapine in Treatment of Schizophrenia: A Double Blind Clinical Trial
MOJ Addiction Medicine & Therapy
Cost-Effectiveness Model Comparing Olanzapine and Other Oral Atypical Antipsychotics in the Treatment of Schizophrenia in the United States
Cost Effectiveness and Resource Allocation
Health Policy
Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients
Journal of Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
Pmh40 - Cost-Minimisation Analysis of Second Generation Long Acting Injectables (Risperidone , Paliperidone, and Aripiprazole) for Schizophrenia in Spanish Medium-Long Term Care Psychiatric Units
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Term Safety and Efficacy of Olanzapine Long-Acting Injection in Patients With Schizophrenia or Schizoaffective Disorder
International Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
